News and Trends 7 Nov 2016
Results from 45% of Clinical Trials are kept Secret
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the most clinical trial results unreported.…
Roche
- Latest Posts
News and Trends 4 Nov 2016
Roche hits a Speed Bump on the way to a Hemophilia Cure
The Swiss pharma is gearing up for a battle with Novo Nordisk in Hemophilia, but a safety setback might slow…
News and Trends 31 Oct 2016
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a huge success. Now awaiting US…
News and Trends 19 Oct 2016
The ‘First and Only’ Metastatic Lung Cancer Immunotherapy is approved
Roche's Genentech has received FDA approval for an immunotherapy targeting the highly sought-after PD-L1. The treatment may be able to…
ADVERTISEMENT
News and Trends 10 Oct 2016
Big Pharmas Battle to be the Lung Cancer Leader at ESMO
Merck, Roche and BMS have unveiled updated results in Copenhagen as the companies duke it out for the leadership in…
News and Trends 21 Sep 2016
German Biotech allies with Genentech in battle for Cancer Vaccine
BioNTech has turned up the heat in the race to bring an mRNA immunotherapy for cancer to the clinic. The…
News and Trends 15 Sep 2016
Roche’s New Antibody is besting the best MS Drug
Roche is poised to blow away the competition for the new multiple sclerosis drug with its leading candidate, Ocrevus (ocrelizumab).…
News and Trends 4 Aug 2016
Roche drops Partnership for Hepatitis Immunotherapy
While everybody wants to get the next immunotherapy on the market, Roche is turning its back on one. It's leaving…
News and Trends 30 May 2016
Roche debuts new MedTech for needle-free management of Diabetes
Roche is making progress in its Diabetes Care unit. It has struck a deal with the MedTech company Senseonics to…
News and Trends 18 Mar 2016
Roche signs a €900M deal with an Immunotherapy Biotech in Boston
Roche (Switzerland) has picked 5 candidates from Blueprint Medicines (US) to complement its leading oncology pipeline. Roche is a leader…
ADVERTISEMENT
News and Trends 9 Dec 2015
Squeezing Cells: A Revolutionary Cancer Drug Delivery Platform for €455M?
The MIT spin-off SQZ Biotech has an invention (Cell SQueeZe) which could make vector drug delivery in Cancer a thing of…
News and Trends 23 Oct 2015
#Sorry: The World-leading Oncology Company fails in Phase III
Antibody Drug Conjugate is a smart way to improve chemotherapy. That is the strategy of Roche / Immunogen's drug Kadcyla®, which…
News and Trends 14 Oct 2015
No, Novartis and Roche won’t merge (yet)!
Novartis already owns 33% of Roche, but even if both companies are headquartered in the same city of Basel (Switzerland),…
News and Trends 12 Oct 2015
Roche dishes out €509M for a Humanized antibody against Rheumatoid Arthritis
Adheron Therapeutics is a small California (US) biotech which has developed a phase I monoclonal antibody (mAb) therapy for inflammatory…
News and Trends 9 Oct 2015
TauRX, the leading Alzheimer-focused Biotech, earns funding after Phase II breakthrough
The Tau protein has already been implicated in the onset of Alzheimer's, with many biotechs on the hunt for a…
News and Trends 3 Oct 2015
What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes
Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping) Tuesday: Will Roche lose it’s Worldwide Leading position in…
ADVERTISEMENT
News and Trends 29 Sep 2015
Will Roche lose its Worldwide Leading position in Cancer treatments?
Roche is the worldwide leader in cancer treatments, but it's threatened by the increasing competition of biosimilars and the development…
News and Trends 25 Sep 2015
Roche’s patent halts an Amgen biosimilar debut
Amgen has had great success with its Avastin biosimilar, used as an inhibitor of angiogenesis in tumor growth. However, despite…
News and Trends 10 Sep 2015
Roche adds AveXis to its SMA portfolio – determined to dominate market
Swiss Roche is looking to dominate market in Spinal Muscular Atrophy (SMA) research, now also investing in AveXis as part…
News and Trends 1 Sep 2015
Genentech’s Sean Bohen defects to AstraZeneca as CMO
AstraZeneca's Senior management team gets reinforced by Sean Bohen, a top executive from Roche's subsidiary Genentech. Starting in two weeks,…